Drug intelligence / Profile preview

Dexosome

Development stage
Phase 2
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

**Dexosome** is a cell-free therapeutic vaccine derived from dendritic cells (DCs) loaded with tumor-associated antigens (TAAs) for cancer immunotherapy. It leverages exosomes secreted by DCs to present antigens, activating both adaptive (T lymphocytes) and innate (natural killer cells) immune responses against tumors. Dexosomes have demonstrated antitumor activity in preclinical mouse models and safety in human clinical trials, including phase I studies in advanced non-small cell lung carcinoma (NSCLC) and phase II in malignant melanoma, without significant adverse effects.[2][5]

Other names
dexosomes
02

Targets

CD80/CD86 costimulatory receptors axisIntercellular adhesion molecule 1/integrin adhesion axisγδ TCR (T-cell receptor)NCR3 (Natural cytotoxicity trigger receptor 3 (NKp30))NKG2D (Natural killer group 2 member D receptor)

Beyond the preview

Go deeper on Dexosome.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dexosome.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call